FENIX decided to launch a new syndicated service that leverages its extensive expertise in cardiometabolics and offer a new digestible way to contextualize the market. The new service utilized the technology platform built by FENIX Labs.

The FENIX syndicated service in cardiometabolics included:

Contextualized, summarized and updated market landscape news delivered directly to the user’s inbox. All blasts are also cloud-hosted at marketplace.fenix.group where they can be searched and accessed at any time across devices. This is part of the push experience.

Launching FENIXapp was a true milestone for FENIX Labs since it was fully developed in-house. Available in both Google Play and the Apple App Store. Our app includes push notifications for blasts, favorited content, and filtering by category. This is part of the push experience.

Experience the diabetes market landscape in a unique digital interface and interact with our extensive knowledge repository in a non-linear space. Pin your points of interest which are then saved to the cloud, updated in real time, and synced on all your devices. View your history in a breadcrumb format, so you can always find your way back. Level-up with search. This is part of the pull experience.

Profiling across therapy areas is a key part of FENIX’s service and is common practice across the life sciences industry. Our platform was engineered by FENIX Labs for scale to be dynamically responsive under any consumption scenario. Our profiles render content from a centralized database, so you can access them at any time across devices without being stuck inside a PPTX file. This is part of the pull experience.